---
figid: PMC4807882__bcbcr-10-2016-025f3
figlink: /pmc/articles/PMC4807882/figure/f3-bcbcr-10-2016-025/
number: F3
caption: 'Schematic overview of the therapeutic targets that are currently being tested
  in clinical trials among patients with mTNBC.Abbreviations: PI3K, phosphatidylinositol
  3-kinase; MEK, mitogen-activated protein kinase kinase; Akt, v-Akt murine thymoma
  viral oncogene; mTOR, mammalian target of rapamycin; HSP-90, heat shock protein
  90; CXCR, chemokine receptor; HDAC, histone deacetylase; PARP, poly adenosine diphosphate-ribose
  polymerase; Trop-2, tumor-associated calcium signal transducer 2; GPNMB, glycoprotein
  nonmetastatic b; EGFR, epidermal growth factor receptor; VEGFR, vascular endothelial
  growth; PD1, programmed death 1; PDL1, programmed death ligand 1; CTLA4, cytotoxic
  T-lymphocyte-associated protein 4; AR, androgen receptor; CYP17A1, cytochrome P450
  17A1; CSF1R, colony-stimulating factor 1 receptor; JAK1/2, janus kinase 1 and 2;
  Sine XPO1, selective inhibitor of nuclear export exportin 1; VDR, vitamin D pathway
  receptor genes; HMGCR, HMG-CoA reductase; RAS, rat sarcoma; RAF, B-raf and v-Raf
  murine sarcoma viral oncogene homolog B; ERK, extracellular signal-regulated kinases;
  STAT, signal transducer and activator of transcription; GRB2, growth factor receptor-bound
  protein 2; TNBC, triple-negative breast cancer.'
pmcid: PMC4807882
papertitle: A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer.
reftext: Simon B. Zeichner, et al. Breast Cancer (Auckl). 2016;10:25-36.
pmc_ranked_result_index: '202601'
pathway_score: 0.8993799
filename: bcbcr-10-2016-025f3.jpg
figtitle: A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer.
year: '2016'
organisms:
- Homo sapiens
ndex: 53ac4142-df10-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4807882__bcbcr-10-2016-025f3.html
  '@type': Dataset
  description: 'Schematic overview of the therapeutic targets that are currently being
    tested in clinical trials among patients with mTNBC.Abbreviations: PI3K, phosphatidylinositol
    3-kinase; MEK, mitogen-activated protein kinase kinase; Akt, v-Akt murine thymoma
    viral oncogene; mTOR, mammalian target of rapamycin; HSP-90, heat shock protein
    90; CXCR, chemokine receptor; HDAC, histone deacetylase; PARP, poly adenosine
    diphosphate-ribose polymerase; Trop-2, tumor-associated calcium signal transducer
    2; GPNMB, glycoprotein nonmetastatic b; EGFR, epidermal growth factor receptor;
    VEGFR, vascular endothelial growth; PD1, programmed death 1; PDL1, programmed
    death ligand 1; CTLA4, cytotoxic T-lymphocyte-associated protein 4; AR, androgen
    receptor; CYP17A1, cytochrome P450 17A1; CSF1R, colony-stimulating factor 1 receptor;
    JAK1/2, janus kinase 1 and 2; Sine XPO1, selective inhibitor of nuclear export
    exportin 1; VDR, vitamin D pathway receptor genes; HMGCR, HMG-CoA reductase; RAS,
    rat sarcoma; RAF, B-raf and v-Raf murine sarcoma viral oncogene homolog B; ERK,
    extracellular signal-regulated kinases; STAT, signal transducer and activator
    of transcription; GRB2, growth factor receptor-bound protein 2; TNBC, triple-negative
    breast cancer.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT6
  - PARP10
  - HSP90AB1
  - TNKS2
  - SRC
  - PARP12
  - PARP8
  - PDCD1
  - PARP9
  - STAT4
  - TNKS
  - PARP15
  - VDR
  - HRAS
  - AKT1
  - STAT2
  - STAT1
  - STAT3
  - MAP2K1
  - STAT5A
  - STAT5B
  - MAPK1
  - GRB2
  - TRAP1
  - PARP4
  - KRAS
  - HSP90B1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - AR
  - MTOR
  - PARP11
  - PARP2
  - MAPK3
  - BRAF
  - RAF1
  - PARP6
  - TIPARP
  - PARP14
  - PARP16
  - CXCR1
  - AKT2
  - ARAF
  - CTLA4
  - PARP1
  - CYP17A1
  - NRAS
  - PARP3
  - AKT3
  - EGF
  - MAP2K2
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PD1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: VDR
  symbol: VDR
  source: hgnc_symbol
  hgnc_symbol: VDR
  entrez: '7421'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Akt*
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: CXCR1
  symbol: CXCR1
  source: hgnc_symbol
  hgnc_symbol: CXCR1
  entrez: '3577'
- word: Akt*
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: CTLA4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: CYP17
  symbol: CYP17
  source: hgnc_prev_symbol
  hgnc_symbol: CYP17A1
  entrez: '1586'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: Akt*
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4807882__F3
redirect_from: /figures/PMC4807882__F3
figtype: Figure
---
